Literature DB >> 27889282

Neuromodulation Treatments for Geriatric Mood and Cognitive Disorders.

William M McDonald1.   

Abstract

There is increasing evidence for the efficacy of neuromodulation in the treatment of resistant mood disorders and emerging data supporting the use of neuromodulation in cognitive disorders. A significant minority of depressed elders do not respond to pharmacotherapy and/or psychotherapy. This has led clinicians to recommend the increasing use of electroconvulsive therapy (ECT) in the treatment of medication-resistant or life-threatening geriatric depression. Multiple studies have supported the safety and efficacy of ECT in the elderly, yet ECT is associated with side effects including cardiovascular and cognitive side effects. Neuromodulation therapies have the potential for providing effective treatment for treatment-resistant older adults with reduced side effects and this review will outline the risks and benefits of neuromodulation treatment in geriatric psychiatry. There is also emerging evidence of the efficacy of neuromodulation devices in the treatment of cognitive disorders. Pharmacotherapy has been largely ineffective in changing the course of neurodegenerative diseases causing dementia and other treatments are clearly needed. This review will outline the available evidence for neuromodulation in the treatment of mood and cognitive disorders in the elderly. Copyright Â
© 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DBS; Depression; ECT; TMS; dementia; neuromodulation; tDCS

Mesh:

Year:  2016        PMID: 27889282     DOI: 10.1016/j.jagp.2016.08.014

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

Review 1.  Strategies for dementia prevention: latest evidence and implications.

Authors:  Gopalkumar Rakesh; Steven T Szabo; George S Alexopoulos; Anthony S Zannas
Journal:  Ther Adv Chronic Dis       Date:  2017-06-27       Impact factor: 5.091

Review 2.  Neuromodulation of cognition in Parkinson's disease.

Authors:  Rachel C Cole; Derrick N Okine; Brooke E Yeager; Nandakumar S Narayanan
Journal:  Prog Brain Res       Date:  2022-02-11       Impact factor: 2.624

3.  The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.

Authors:  Sanne J H van Rooij; Patricio Riva-Posse; William M McDonald
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-03

Review 4.  Evaluation and treatment of older-age bipolar disorder: a narrative review.

Authors:  Rajesh R Tampi; Pallavi Joshi; Gargi Bhattacharya; Sheila Gupta
Journal:  Drugs Context       Date:  2021-05-27

Review 5.  Depression and chronic heart failure in the elderly: an intriguing relationship.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giuseppe Sasso; David Della-Morte; Gaetano Gargiulo; Flora Pirozzi; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete; Gianluca Testa
Journal:  J Geriatr Cardiol       Date:  2018-06       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.